by Ken Chiacchia | Oct 3, 2022 | Bridges-2, Science Highlights, Science Highlights Overview pages, What's new on Bridges-2
The Coma Cluster contains more than 1,000 galaxies. Scientists have long been frustrated by large uncertainties in its mass. Predicted mass of huge Coma Cluster agrees with earlier, human-intensive attempts; offers fast, accurate measurement needed to understand early...
by Ken Chiacchia | Aug 4, 2022 | Science Highlights
Articles need a featured image for social media & the website. Keep it full width. Description can go on this line here with photo credits. Adobe Stock Subtitle Heading 2 Dark Grey #403e3d Subtitle Heading 2 Dark Grey #403e3d #403e3d Quantum computers promise...
by Ken Chiacchia | Jun 29, 2022 | 2022 Science Highlights, Science Highlights
Work establishes benchmark for beating classical computers, optimizes quantum performance Quantum computers promise vastly expanded computing power. But they’ve yet to prove beyond a doubt that they’re faster than classical computers for specific tasks. It isn’t even...
by Ken Chiacchia | May 11, 2022 | 2022 Science Highlights, Science Highlights
Images derived from crystal structures help neural network running on Bridges-2 to predict ability to create a given crystal in the real world To create new electronic and other tools, materials scientists need new types of crystals with specific electrical and...
by Ken Chiacchia | Mar 23, 2022 | 2022 Science Highlights, Science Highlights
anton 2 sims suggest how fish oil health benefits start at cell membrane Molecular simulations coupled with AI analysis reveal how omega-3 polyunsaturated fatty acids may regulate the size of membrane “rafts” The omega-3 polyunsaturated fatty acids...
by Ken Chiacchia | Feb 23, 2022 | 2022 Science Highlights, COVID-19, News, Science Highlights
Electrical Charge of Vaccine Particles May Lead toBlood-clot side effect Bridges-2 simulations suggest complication may stem from oppositely charged clot-forming protein sticking to engineered adenovirus Despite the lifesaving success of the COVID-19 vaccines,...
